Cytek Biosciences (CTKB) Asset Utilization Ratio (2021 - 2026)
Cytek Biosciences' (CTKB) quarterly Asset Utilization Ratio came in at 0.45 in Q1 2026, up 11.74% YoY from 0.4 in Q1 2025, and up 6.43% on a QoQ basis from 0.42 in Q4 2025.
Cytek Biosciences (CTKB) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 6 years of Asset Utilization Ratio data on file, last reported at 0.45 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 11.74% year-over-year to 0.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.45 (up 11.74% YoY) and the FY2025 annual result came in at 0.42, up 3.96% from the prior year.
- Asset Utilization Ratio improved to 0.45 in Q1 2026, from 0.42 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q1 2026 to a low of 0.29 in Q1 2022.
- A 5-year average of 0.37 and a median of 0.4 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio dropped 10.86% — and 2024, when it gained 27.96%.
- Tracing CTKB's Asset Utilization Ratio over 5 years: stood at 0.32 in 2022, then rose by 18.23% to 0.38 in 2023, then advanced by 6.28% to 0.4 in 2024, then grew by 4.12% to 0.42 in 2025, then increased by 6.43% to 0.45 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.45 (Q1 2026), 0.42 (Q4 2025), and 0.4 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.56 |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.46 |
| Mar 31, 2026 | 0.45 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.40 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.41 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.32 |
| Sep 30, 2022 | 0.31 |
| Jun 30, 2022 | 0.30 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.28 |
| Sep 30, 2021 | 0.35 |